Chemify scales up operations at Health Innovation Hub
Digital chemistry company Chemify is set to embark on the next phase of its business journey with a strategic relocation to Glasgow’s newest purpose-built life science facility, Health Innovation Hub (HiH).
Chemify, a pioneer in developing technology to provide pharmaceutical, biotechnology and industrial partners with better molecules, will occupy more than 40,000 sq ft across two floors with additional space on the ground floor of HiH. This represents the largest commercial letting of the year so far for life sciences in Glasgow,…
Cambridge, UK – Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process development, and GMP manufacturing.Cell therapy is rapidly transforming modern medicine, offering new hope for patients with cancer, autoimmune conditions, and genetic disorders. However, the development and manufacturing of these therapies demand reagents of uncompromising quality, consistency, and safety.…
International Experts to Help Drive Company Success as it Launches its Series A fundraising
Norwich, UK, September 30 2025 – Ikarovec, a leader in ophthalmology gene therapy innovation with a sophisticated field-changing technology for the long-term relief of prevalent eye diseases, has established a world-leading Scientific Advisory Board (SAB) of retinal research and clinical care specialists. The SAB, comprising a Clinical Translation Council and a Discovery Research Council, will advise the company across its activities from preclinical research through to clinical trials, regulatory…
Looking Forward to a Golden Autumn
Welcome to this month's eNews
Tony Jones, CEO, One Nucleus
It is hard to describe the news flow and activity in the Life Sciences sector as anything but an emotional rollercoaster for most in the sector. The worrisome news of large Pharma withdrawing or placing under review R&D investment in the UK, along with continuing news of financing challenges and staff redundancies, has profound implications for many.
There have been some brighter activities too. Deals completed, vacancies advertised, energetic gatherings reminding us that the…
Learn to Discover (L2D) is a cutting edge, fully supported online training course and learning platform, empowering researchers with powerful knowledge and skills to unlock their data. Our modules cover:Python programmingData handlingNetwork scienceMachine learning Artificial Intelligence (AI) Our courses are tailored for health, disease and bioscience researchers and industry. The course is accredited for CPD purposes by the Federation of the Royal Colleges of Physicians…
Oxford, UK, 25 September 2025: Miebach Consulting (“Miebach”), the strategic supply chain partner for global markets, today announced it has expanded its facilities at Abingdon Science Park delivered by Kadans Science Partner (“Kadans”), a leading investor in the development of real estate with a focus on knowledge intensive sectors. The new unit offers affordable, flexible office space within The Science Quadrant, doubling Miebach’s footprint on the park and representing a major milestone in the Company’s expansion.
As a long-standing occupier at Abingdon Science Park, Miebach offers…
LONDON, October 1, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Parkinson’s UKand is pleased to announce the placement of Dr. Lynsey Bilsland as Managing Director of Parkinson’s Virtual Biotech.The Parkinson's Virtual Biotech is the global drug discovery and development program of Parkinson’s UK. Driven by the Parkinson’s community, it is investing strategically to deliver crucial life-changing therapies faster.Dr. Bilsland brings extensive experience…
PACE (Pathways to Antimicrobial Clinical Efficacy) launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health.
To stay ahead of the escalating antibiotic resistance crisis, we need bold thinking and transformative innovation. According to the World Health Organization (WHO), over 80% of recently approved bacterial antimicrobial agents show similarities to existing drug classes, meaning their potential is limited as resistance mechanisms to these classes already exist. Without significant action…
Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Joe Torres-Ocasio as Senior Vice President and Chief Operating Officer (COO). Joe will lead Veranova’s global operations across its manufacturing network in Europe and North America, and will also oversee the company’s Engineering, Environmental Health & Safety (EHS) and Supply Chain/Operational Excellence functions.
Prior to joining Veranova, he…
ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and SLAS will provide delegates with the opportunity for cross-event partnering during London Bio-Innovation week, which runs 1-5 December, 2025
One Nucleus’ Genesis conference partnering app open to delegates attending any of the Bio-innovation Week events
Initiative to provide extended opportunities for networking, to support the life science ecosystem
London, UK, 30 September 2025: ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and The Society for Laboratory Automation…